Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 3,643 | 3,957 | 3,248 |
| Operating Income | -3,643 | -3,957 | -3,248 |
| Other Income | 1 | 3 | 63 |
| Pre-tax Income | -3,642 | -3,954 | -3,185 |
| Net Income Continuous | -3,642 | -3,954 | -3,185 |
| Net Income | $-3,642 | $-3,954 | $-3,185 |
| EPS Basic Total Ops | -3.68 | -7.43 | -7.57 |
| EPS Basic Continuous Ops | -3.68 | -7.43 | -7.58 |
| EPS Diluted Total Ops | -3.68 | -7.43 | -7.57 |
| EPS Diluted Continuous Ops | -3.68 | -7.43 | -7.58 |
| EBITDA(a) | $-3,593 | $-3,912 | $-3,208 |